文献速递乳腺乳腺X线

对比增强乳腺X线摄影:诊断性能的系统综述与Meta分析

Contrast-enhanced Mammography: A Systematic Review and Meta-Analysis of Diagnostic Performance.
PubMed 文献 · Radiology · 2021-12-14

该系统综述与Meta分析纳入60项研究(67个研究部分,10 605例患者共11 049次对比增强乳腺X线摄影检查),评估其诊断性能。合并HSROC曲线下面积为0.94(95%CI:0.91,0.96),合并诊断比值比为55.7(95%CI:42.7,72.7),异质性高(τ2=0.3)。同时判读低能量图与重组图较仅判读重组图敏感度更高(95% vs 94%,P<.001)、特异度更高(81% vs 71%,P=.03)。

要点

  • 同时判读低能量图与重组图的敏感度95% vs 仅重组图94%(P<.001),特异度81% vs 71%(P=.03)。
  • 致密乳腺9项研究合并敏感度95%(95%CI:92,97)、特异度78%(95%CI:66,87)。
  • 乳腺X线检出可疑病灶10项研究合并敏感度92%(95%CI:89,94)、特异度84%(95%CI:73,91)。

核心结论

  • 对比增强乳腺X线摄影在乳腺癌检出中表现出高性能,尤其是联合判读低能量图与重组图时。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE、EMBASE、Web of Science和Cochrane Library数据库至2021年7月15日。
  • 纳入以前瞻性或回顾性设计评估对比增强乳腺X线摄影诊断性能、以组织病理学和/或随访为参考标准的研究。
  • 共纳入60项研究(67个研究部分,10 605例患者,11 049次对比增强乳腺X线摄影检查),采用诊断准确性研究质量评估2工具评价研究质量。

诊断标准与关键数值

  • 总体HSROC曲线下面积0.94(95%CI:0.91,0.96),合并诊断比值比55.7(95%CI:42.7,72.7),异质性高(τ2=0.3)。
  • 同时判读低能量图与重组图较仅判读重组图敏感度更高(95% vs 94%,P<.001)、特异度更高(81% vs 71%,P=.03)。
  • 致密乳腺患者9项研究合并敏感度95%(95%CI:92,97)、合并特异度78%(95%CI:66,87)。
  • 乳腺X线检出可疑病灶的10项研究合并敏感度92%(95%CI:89,94)、合并特异度84%(95%CI:73,91)。

临床应用与阅片要点

  • 阅片与报告对比增强乳腺X线摄影时,宜同时判读低能量图与重组图,原文显示该判读方式敏感度与特异度均高于仅判读重组图。
  • 在致密乳腺患者中,原文报告的合并敏感度为95%(95%CI:92,97)、合并特异度为78%(95%CI:66,87)。
  • 在乳腺X线检出可疑病灶时,原文报告的合并敏感度为92%(95%CI:89,94)、合并特异度为84%(95%CI:73,91)。

局限性

  • 原文报告异质性高(τ2=0.3)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Contrast-enhanced mammography (CEM) is a promising technique for breast cancer detection, but conflicting results have been reported in previous meta-analyses. Purpose To perform a systematic review and meta-analysis of CEM diagnostic performance considering different interpretation methods and clinical settings. Materials and Methods The MEDLINE, EMBASE, Web of Science, and Cochrane Library databases were systematically searched up to July 15, 2021. Prospective and retrospective studies evaluating CEM diagnostic performance with histopathology and/or follow-up as the reference standard were included. Study quality was assessed with the Quality Assessment of Diagnostic Accuracy Studies 2 tool. Summary diagnostic odds ratio and area under the receiver operating characteristic curve were estimated with the hierarchical summary receiver operating characteristic (HSROC) model. Summary estimates of sensitivity and specificity were obtained with the hierarchical bivariate model, pooling studies with the same image interpretation approach or focused on the same findings. Heterogeneity was investigated through meta-regression and subgroup analysis. Results Sixty studies (67 study parts, 11 049 CEM examinations in 10 605 patients) were included. The overall area under the HSROC curve was 0.94 (95% CI: 0.91, 0.96). Pooled diagnostic odds ratio was 55.7 (95% CI: 42.7, 72.7) with high heterogeneity (τ2 = 0.3). At meta-regression, CEM interpretation with both low-energy and recombined images had higher sensitivity (95% vs 94%, P < .001) and specificity (81% vs 71%, P = .03) compared with recombined images alone. At subgroup analysis, CEM showed a 95% pooled sensitivity (95% CI: 92, 97) and a 78% pooled specificity (95% CI: 66, 87) from nine studies in patients with dense breasts, while in 10 studies on mammography-detected suspicious findings, CEM had a 92% pooled sensitivity (95% CI: 89, 94) and an 84% pooled specificity (95% CI: 73, 91). Conclusion Contrast-enhanced mammography demonstrated high performance in breast cancer detection, especially with joint interpretation of low-energy and recombined images. © RSNA, 2021 Online supplemental material is available for this article. See also the editorial by Bahl in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Cozzi, Magni, Zanardo, et al. Contrast-enhanced Mammography: A Systematic Review and Meta-Analysis of Diagnostic Performance. Radiology. 2021. PMID: 34904875. doi:10.1148/radiol.211412

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。